Literature DB >> 12867435

Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding.

C Axel Innis1, Marko Hyvönen.   

Abstract

Follistatin associates with transforming growth factor-beta-like growth factors such as activin or bone morphogenetic proteins to form an inactive complex, thereby regulating processes as diverse as embryonic development and cell secretion. Although an interaction between heparan sulfate chains present at the cell surface and follistatin has been recorded, the impact of this binding reaction on the follistatin-mediated inhibition of transforming growth factor-beta-like signaling remains unclear. To gain a structural insight into this interaction, we have solved the crystal structure of the presumed heparan sulfate-binding domain of follistatin, both alone and in complex with the small heparin analogs sucrose octasulfate and D-myo-inositol hexasulfate. In addition, we have confirmed the binding of the sucrose octasulfate and D-myo-inositol hexasulfate molecules to this follistatin domain and determined the association constants and stoichiometries of both interactions in solution using isothermal titration calorimetry. Overall, our results shed light upon the structure of this follistatin domain and reveal a novel conformation for a hinge region connecting epidermal growth factor-like and Kazal-like subdomains compared with the follistatin-like domain found in the extracellular matrix protein BM-40. Moreover, the crystallographic analysis of the two protein-ligand complexes mentioned above leads us to propose a potential location for the heparan sulfate-binding site on the surface of follistatin and to suggest the involvement of residues Asn80 and Arg86 in such a follistatin-heparin interaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867435     DOI: 10.1074/jbc.M211284200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).

Authors:  Thomas F Lerch; Michael S Chapman
Journal:  Virology       Date:  2011-12-09       Impact factor: 3.616

2.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

3.  The process-inducing activity of transmembrane agrin requires follistatin-like domains.

Authors:  Elmar Porten; Beate Seliger; Verena A Schneider; Stefan Wöll; Daniela Stangel; Rene Ramseger; Stephan Kröger
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

4.  Analysis of the interaction between heparin and follistatin and heparin and follistatin-ligand complexes using surface plasmon resonance.

Authors:  Fuming Zhang; Julie M Beaudet; David M Luedeke; Ryan G Walker; Thomas B Thompson; Robert J Linhardt
Journal:  Biochemistry       Date:  2012-08-13       Impact factor: 3.162

5.  Disorder and cysteines in proteins: A design for orchestration of conformational see-saw and modulatory functions.

Authors:  Anukool A Bhopatkar; Vladimir N Uversky; Vijayaraghavan Rangachari
Journal:  Prog Mol Biol Transl Sci       Date:  2020-06-27       Impact factor: 3.622

6.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

7.  Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry.

Authors:  Yonghao Yu; Matthew D Sweeney; Ola M Saad; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2006-02-28       Impact factor: 3.109

Review 8.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

9.  Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.

Authors:  Suryakala Sarilla; Sally Y Habib; Dmitri V Kravtsov; Anton Matafonov; David Gailani; Ingrid M Verhamme
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

10.  Drosophila Follistatin exhibits unique structural modifications and interacts with several TGF-beta family members.

Authors:  Daniela Bickel; Ripal Shah; Scott C Gesualdi; Theodor E Haerry
Journal:  Mech Dev       Date:  2007-10-05       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.